Durability of anti-vascular endothelial growth factor agents in neovascular age-related macular degeneration

被引:0
|
作者
Sivaprasad, Sobha [1 ]
机构
[1] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England
来源
关键词
THERAPY;
D O I
10.1111/ceo.13973
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:540 / 541
页数:2
相关论文
共 50 条
  • [31] Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
    Hanhart, Joel
    Wiener, Rony
    Totah, Hashem
    Gelman, Evgeny
    Weill, Yishay
    Abulafia, Adi
    Zadok, David
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (06) : 1907 - 1914
  • [32] Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration
    Veloso, Carlos E.
    Kanadani, Tereza M.
    Pereira, Frederico B.
    Nehemy, Marcio B.
    OPHTHALMOLOGY, 2015, 122 (08) : 1569 - 1572
  • [33] Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration
    Jung, Jesse J.
    Hoang, Quan V.
    Arain, Mohammad Z. Y.
    Chang, Stanley
    ACTA OPHTHALMOLOGICA, 2016, 94 (03) : E249 - E250
  • [34] The Impact of Anti-Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration
    Finger, Robert P.
    Guymer, Robyn H.
    Gillies, Mark C.
    Keeffe, Jill E.
    OPHTHALMOLOGY, 2014, 121 (06) : 1246 - 1251
  • [35] Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    Maguire, Maureen G.
    JAMA OPHTHALMOLOGY, 2018, 136 (08) : 884 - 885
  • [36] Geographic Atrophy in Patients Receiving Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration
    Xu, Luna
    Mrejen, Sarah
    Jung, Jesse J.
    Gallego-Pinazo, Roberto
    Thomson, Desmond
    Marsiglia, Marcela
    Boddu, Sucharita
    Freund, K. Bailey
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [37] Endophthalmitis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Neovascular Age-Related Macular Degeneration
    Moshfeghi, Andrew A.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 139 - 148
  • [38] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: Same, same but different
    Fung, Adrian T.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (03): : 270 - 273
  • [39] Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration
    Dedania, Vaidehi S.
    Bakri, Sophie J.
    CURRENT OPINION IN OPHTHALMOLOGY, 2016, 27 (03) : 224 - 243
  • [40] Treatment of Neovascular Age-Related Macular Degeneration An Economic Cost-Risk Analysis of Anti-Vascular Endothelial Growth Factor Agents
    Moisseiev, Elad
    Tsai, Yi-Lin
    Herzenstein, Michal
    OPHTHALMOLOGY RETINA, 2022, 6 (03): : 205 - 212